Read-Gene S.A. (WSE:RDG)
4.040
-0.260 (-6.05%)
Last updated: Jun 3, 2025
Read-Gene Revenue
Read-Gene had revenue of 3.76M PLN in the quarter ending March 31, 2025, with 77.63% growth. This brings the company's revenue in the last twelve months to 14.49M, up 34.70% year-over-year. In the year 2024, Read-Gene had annual revenue of 12.85M with 26.62% growth.
Revenue (ttm)
14.49M
Revenue Growth
+34.70%
P/S Ratio
3.64
Revenue / Employee
805.26K
Employees
22
Market Cap
52.82M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.85M | 2.70M | 26.62% |
Dec 31, 2023 | 10.15M | 2.91M | 40.14% |
Dec 31, 2022 | 7.24M | 787.35K | 12.20% |
Dec 31, 2021 | 6.45M | 384.57K | 6.34% |
Dec 31, 2020 | 6.07M | -296.62K | -4.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.82B |
Synektik Spólka Akcyjna | 556.63M |
Voxel | 556.98M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Centrum Medyczne ENEL-MED | 735.59M |
Selvita | 359.79M |
EMC Instytut Medyczny | 836.81M |